Bacterial genomic DNA (ATCC 43300, DSM 13661; ATCC 27853, DSM1117; ATCC 700603, DSM 26371; ATCC 25922, DSM 1103; ATCC 19606, DSM 30007; ATCC 51299, DSM 12956; Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures GmbH) or salmon genomic DNA (deoxyribonucleic acid sodium salt from salmon testes, D1626, Merck) dissolved in 1 mM phosphate buffer pH 7.4 (containing 0.27 mM potassium chloride, 13.7 mM sodium chloride) to a concentration of 100 μg/mL in SybrSafe (SYBR Safe DNA Gel Stain, ×10,000 in DMSO, S33102 Invitrogen) was used as supplied by the manufacturer in DMSO, and MGB-BP-3 was prepared as 10 mM stock in DMSO. These stock solutions were diluted appropriately with each other and 1 mM phosphate buffer to give a test solution comprised of 20 μM S-MGB, 12,500-fold dilution of SybrSafe and 3.92 μg/mL DNA. Control solutions of gDNA and SybrSafe, gDNA, and SybrSafe at these concentrations were also prepared. Test and control solutions were heated to 30 °C and the fluorescence of each solution was measured using the SYBER filter setting of a StepOnePlus using melt analysis mode (StepOne Software v2.3). The reduction of fluorescence due to the binding of MGB-BP-3 to the gDNA was calculated as a normalized percentage based on the fluorescence measured due to the control with SybrSafe and gDNA as maximum and the control with only SybrSafe as minimum. Low normalized percentage indicates a greater ability to displace SybrSafe from the gDNA and suggests strong binding to gDNA. Three independent experiments were carried out and the results were presented as average values ± standard error of the mean.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
 Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.